|
Smartwatch Accuracy for Measuring Vitals and Anxiety Before Disc Surgery
RECRUITINGSponsored by Halil Kalaycı
Actively Recruiting
SponsorHalil Kalaycı
Started2025-11-01
Est. completion2026-03-30
Eligibility
Age22 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07322523
Summary
This study aims to verify the accuracy of blood pressure, heart rate, blood oxygen saturation, anxiety level, and sleep cycle data measurements obtained from Samsung smartwatches compared to the currently accepted method used in patients with disc herniation undergoing the preoperative period.
Eligibility
Age: 22 Years+Healthy volunteers accepted
Inclusion Criteria: * 22 years and older * Currently receiving preoperative care/assessment for disc herniation surgery. * No history of any cardiovascular disease other than controlled hypertension. * Willingness to wear the smartwatch for a minimum of 8 consecutive hours during the night before surgery. * Ability to follow all instructions related to the smartwatch operation and data collection independently. * No known allergy to nickel. Exclusion Criteria: * Patients who are currently receiving prescribed medication specifically for sleep in the clinical setting. * Refusal or unwillingness to participate in the study. * The participant fails to wear the smartwatch correctly or appropriately as per study instructions, leading to incomplete or unreliable data collection.
Conditions11
AnxietyCervical Disc HerniationDisc Herniation, LumbarDisc HerniationsPreoperative Anxiety ScorePreoperative CareSleep QualitySmart WatchSurgical NursingVital Signs Monitoring
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorHalil Kalaycı
Started2025-11-01
Est. completion2026-03-30
Eligibility
Age22 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07322523